Current Screening Strategy Poses Risk of Spreading of Hepatitis C Virus Infection
Risk of HCV Infection Spread
DOI:
https://doi.org/10.37978/tijfs.v5i1.314Keywords:
Cor Antigen, RT-PCR, RNA, HCV, Blood DonorsAbstract
Background: Hepatitis C virus is one of the significant causes of morbidity and mortality in the World. Surprisingly, despite national screening campaigns, new cases of HCV are still on the rise.
Methods and Results: A total of 5914 healthy blood donors was included in this study after informed consent. Anti-HCV ELISA was used to check presence of antigen in participant’s plasma.using Monlisa HCV Antigen-Antibody Ultra kit. Final confirmation was done by using real time PCR considered as a gold standard.
Results: 0.5% of anti-HCV ELISA negative samples showed presence of antigen in plasma, when checked through core Ag detection method.
Conclusion: Our result suggested that HCV core antigen detection and/or combo testing are far safer screening methods for the detection of HCV and the use of these methods can avoid/reduce further spread of this deadly disease.
References
Ullah S, Rehman HU and Idrees M. Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection European Journal of Gastroenterology &Hepatology 25(10):1146-51(2013). doi:10.1097/MEG.0b013e328360aeb4. DOI: https://doi.org/10.1097/MEG.0b013e328360aeb4
Esteban JI, Gómez J, Martell M et al. Transmission of hepatitis C virus by a cardiac surgeon. New England Journal of Medicine 334(9),555-561(1996). DOI: 10.1056/NEJM199602293340902 DOI: https://doi.org/10.1056/NEJM199602293340902
Ali Q1 KI, Ullah S1. Predictive value of IL-28B rs12979860 variants for peg-IFN, sofosbuvir plus ribavirin treatment of HCV infection in Pakistani population. Per Med. (2018). https://doi.org/10.2217/pme-2018-0012 DOI: https://doi.org/10.2217/pme-2018-0012
Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nature reviews Gastroenterology & hepatology 10(9), 553 (2013). doi: 10.1038/nrgastro.2013.107 DOI: https://doi.org/10.1038/nrgastro.2013.107
Lavanchy D. The global burden of hepatitis C. Liver International 29 74-81 (2009). https://doi.org/10.1111/j.14783231.2008.01934.x DOI: https://doi.org/10.1111/j.1478-3231.2008.01934.x
Nazir N, Jan MR, Ali A et al. Prevalence of hepatitis-C virus genotypes and potential transmission risks in Malakand Khyber Pakhtunkhwa, Pakistan. Virology journal 14(1), 160 (2017). DOI: https://doi.org/10.1186/s12985-017-0829-y
Ali Q, Jamal A, Imran M et al. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study. Personalized medicine 15(6), (2018). DOI: 10.2217/pme-2018-0016 DOI: https://doi.org/10.2217/pme-2018-0016
Ullah S AF, Waqar Ab, Jamal A. Novel Distribution of HCV genotypes and their Main Routes of Infection in the Punjab Pakistan. Biomed J Sci&Tech Res 1((4)), (2017). DOI: 10.26717/BJSTR.2017.01.000340 DOI: https://doi.org/10.26717/BJSTR.2017.01.000340
Kalam I, Ullah S, Ali Q, Jamal A, Waqar AB. Impact of IL28B gene variants (rs12979860) in peg-IFN therapy against Chronic Hepatitis B Pakistani patients. Advancements in Life Sciences 6(1), 11-18 (2018).
Rasheed A, Ullah S, Naeem S, Zubair M, Ahmad W, Hussain Z. Occurrence of HCV genotypes in different age groups of patients from Lahore, Pakistan. Advancements in Life Sciences 1(2), 89-95 (2014).
Saeed MA, Ahmed N, Ali Q. Frequency of Autoantibodies to Thyroid Peroxidase (TPO) in Patients with Type 1 Diabetes Mellitus. (2018).
Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays. Asian journal of transfusion science 8(1), 19 (2014). DOI: https://doi.org/10.4103/0973-6247.126683
Ullah S, Ahmad F, Waqar AB, Jamal A, Ali Q, Imran M, Idrees M, The Evolution of the Hepatitis C Genotypes and probable risk factors for infection:RMES--MRW-572 (2017). DOI: https://doi.org/10.31031/RMES.2017.02.000546
Pawlotsky J-M, Feld JJ, Zeuzem S, Hoofnagle JH. From non-A, non-B hepatitis to hepatitis C virus cure. Journal of hepatology 62(1), S87-S99 (2015). doi: 10.1016/j.jhep.2015.02.006. DOI: https://doi.org/10.1016/j.jhep.2015.02.006
Mandal R, Mondal K. Transfusion Transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India. Journal of traditional and complementary medicine 6(3), 224-229 (2016). https://doi.org/10.1016/j.jtcme.2015.02.003 DOI: https://doi.org/10.1016/j.jtcme.2015.02.003
Laperche S, Le Marrec N, Girault A et al. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. Journal of clinical microbiology 43(8), 3877-3883(2005).doi: 10.1128/JCM.43.8.3877-3883.2005 DOI: https://doi.org/10.1128/JCM.43.8.3877-3883.2005
Huang W, Wei W, Shi XT, Jiang T. The analysis of the detection performance of nucleic acid testing and ELISA for HIV, HBV and HCB. Frontiers in Laboratory Medicine 1(4), 200-202 (2017). DOI: 10.1016/j.flm.2017.12.004 DOI: https://doi.org/10.1016/j.flm.2017.12.004
Atif M, Arshad S, Javaid K et al. Diabetes and Hepatitis C: Two sides of a coin. Advancements in Life Sciences 4(3), 72-76 (2017).
Zhao G, Li G, Zhou X et al. Structural and mutational studies on the importance of oligosaccharide binding for the activity of yeast PNGase. Glycobiology 19(2), 118-125 (2008). https://doi.org/10.1093/glycob/cwn108 DOI: https://doi.org/10.1093/glycob/cwn108
Downloads
Published
Issue
Section
License
Copyright (c) 2021 The International Journal of Frontier Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
